Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

December 31, 2025

Conditions
Neoplasms, Basal CellCarcinoma, Basal CellPhotochemotherapyPhotosensitizing Agents
Interventions
DRUG

Hexylaminolevulinate cream

The cream is mixed up by the Pharmacy Yliopiston Apteekki for the study and every set is analysed by mass spectrometry.

DRUG

Aminolevulinic Acid Nano Emulsion

In the study we use Ameluz.

DRUG

Methylaminolevulinate cream

In the study we use Metvix.

Trial Locations (1)

15850

Joint Authority for Päijät-Häme Social and Health Care, Lahti

All Listed Sponsors
collaborator

Tampere University

OTHER

collaborator

University of Jyvaskyla

OTHER

lead

Joint Authority for Päijät-Häme Social and Health Care

OTHER

NCT02367547 - Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL | Biotech Hunter | Biotech Hunter